Translation. Region: Russian Federal
Source: People’s Republic of China in Russian –
Source: People’s Republic of China – State Council News
SAN FRANCISCO, June 3 (Xinhua) — Elon Musk’s brain-computer interface company Neuralink announced on Monday that it has closed a $650 million funding round.
Investors participating in the Series E round included ARK Invest, Founders Fund, Sequoia Capital and Thrive Capital, the company said in a blog post.
Neuralink last raised funds in a $280 million Series D funding round in 2023, with an additional $43 million tranche raised a few months later.
The company said it had conducted additional human clinical trials, implanting its brain chips in five patients with severe paralysis.
In May, Neuralink received a Breakthrough Devices Program from the Food and Drug Administration (FDA).
According to the FDA, it is a voluntary program for certain medical devices and combination products that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
The goal of the program is to provide patients and health care providers with timely access to medical devices by accelerating their development, evaluation, and review for premarket approval. –0–